» Articles » PMID: 31933062

Inhibition of USP15 Prevent Glutamate-Induced Oxidative Damage by Activating Nrf2/HO-1 Signaling Pathway in HT22 Cells

Overview
Publisher Springer
Date 2020 Jan 15
PMID 31933062
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Oxidative stress has been identified as the significant mediator in epilepsy, which is a chronic disorder in central nervous system. About 30% of epilepsy patients are refractory to antiepileptic drug treatment. However, the underlying mechanism of oxidative damage in epilepsy needs further investigation. In our study, we first find that ubiquitin-specific peptidase 15 (USP15) expression was upregulated in a pentylenetetrazole (PTZ) kindled rat model of epilepsy. Silencing USP15 protected against glutamate-mediated neuronal cell death, and inhibited the high expression levels of cleaved caspase-3. Knockout of USP15 significantly reduced intracellular reactive oxygen species (ROS) levels and enhanced superoxide dismutase (SOD) activity in HT22 cells under the exposure to glutamate treatment. Furthermore, USP15 inhibition induced nuclear factor erythroid-derived 2-related factor2 (Nrf2) nuclear translocation and promoted protein expression level of heme oxygenase (HO-1). Taken together, our findings first reveal a role of USP15 in the pathogenesis of epilepsy, and silencing USP15 in vitro protects against glutamate-mediated cytotoxicity in HT22 cells. Pharmacological inhibition of USP15 may alleviate epileptic seizures via fighting against oxidative damage, providing a novel antiepileptic target.

Citing Articles

USP15 as a Potential Therapeutic Target in Cerebral Ischemia: Modulation of Ferroptosis and Cognitive Dysfunction via the Nrf2/GPX4 Axis in Mice.

Yi H, Xiao X, Lei F, Zhang F Neuromolecular Med. 2024; 26(1):44.

PMID: 39508887 DOI: 10.1007/s12017-024-08813-1.


Downregulation of Ubiquitin-Specific Protease 15 (USP15) Does Not Provide Therapeutic Benefit in Experimental Mesial Temporal Lobe Epilepsy.

Haussler U, Neres J, Vandenplas C, Eykens C, Kadiu I, Schramm C Mol Neurobiol. 2023; 61(4):2367-2389.

PMID: 37874479 PMC: 10973041. DOI: 10.1007/s12035-023-03692-2.


Possible Role of Oxidative Stress and Nrf2/HO-1 Pathway in Pentylenetetrazole-induced Epilepsy in Aged Rats.

Obydah W, Abouelnaga A, Abass M, Saad S, Yehia A, Ammar O Rep Biochem Mol Biol. 2023; 12(1):147-158.

PMID: 37724149 PMC: 10505472. DOI: 10.52547/rbmb.12.1.147.


The Emerging Roles of E3 Ligases and DUBs in Neurodegenerative Diseases.

Liu N, Lin M, Wang Y Mol Neurobiol. 2022; 60(1):247-263.

PMID: 36260224 PMC: 9758110. DOI: 10.1007/s12035-022-03063-3.


Up-and-coming anti-epileptic effect of aloesone in : Evidenced by integrating network pharmacological analysis, , and models.

Wang Y, Li C, Xiong Z, Chen N, Wang X, Xu J Front Pharmacol. 2022; 13:962223.

PMID: 36034878 PMC: 9411719. DOI: 10.3389/fphar.2022.962223.


References
1.
Shekh-Ahmad T, Lieb A, Kovac S, Gola L, Wigley W, Abramov A . Combination antioxidant therapy prevents epileptogenesis and modifies chronic epilepsy. Redox Biol. 2019; 26:101278. PMC: 6692059. DOI: 10.1016/j.redox.2019.101278. View

2.
Torre S, Polyak M, Langlais D, Fodil N, Kennedy J, Radovanovic I . USP15 regulates type I interferon response and is required for pathogenesis of neuroinflammation. Nat Immunol. 2016; 18(1):54-63. DOI: 10.1038/ni.3581. View

3.
Corda M, Giorgi O, Longoni B, Orlandi M, Biggio G . Decrease in the function of the gamma-aminobutyric acid-coupled chloride channel produced by the repeated administration of pentylenetetrazol to rats. J Neurochem. 1990; 55(4):1216-21. DOI: 10.1111/j.1471-4159.1990.tb03127.x. View

4.
Munguia-Martinez M, Nava-Ruiz C, Ruiz-Diaz A, Diaz-Ruiz A, Yescas-Gomez P, Mendez-Armenta M . Immunohistochemical Study of Antioxidant Enzymes Regulated by Nrf2 in the Models of Epileptic Seizures (KA and PTZ). Oxid Med Cell Longev. 2019; 2019:1327986. PMC: 6451808. DOI: 10.1155/2019/1327986. View

5.
Eichhorn P, Rodon L, Gonzalez-Junca A, Dirac A, Gili M, Martinez-Saez E . USP15 stabilizes TGF-β receptor I and promotes oncogenesis through the activation of TGF-β signaling in glioblastoma. Nat Med. 2012; 18(3):429-35. DOI: 10.1038/nm.2619. View